These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38899174)

  • 1. Competing Risks Analysis of Kidney Transplant Waitlist Outcomes: Two Important Statistical Perspectives.
    Gaynor JJ; Guerra G; Vianna R; Tabbara MM; Graell EL; Ciancio G
    Kidney Int Rep; 2024 Jun; 9(6):1580-1589. PubMed ID: 38899174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ABO-Incompatible Living Donor Kidney Transplantation on Patient Survival.
    Massie AB; Orandi BJ; Waldram MM; Luo X; Nguyen AQ; Montgomery RA; Lentine KL; Segev DL
    Am J Kidney Dis; 2020 Nov; 76(5):616-623. PubMed ID: 32668318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond "Median Waiting Time": Development and Validation of a Competing Risk Model to Predict Outcomes on the Kidney Transplant Waiting List.
    Hart A; Salkowski N; Snyder JJ; Israni AK; Kasiske BL
    Transplantation; 2016 Jul; 100(7):1564-70. PubMed ID: 27286174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine-Gray subdistribution hazard models to simultaneously estimate the absolute risk of different event types: Cumulative total failure probability may exceed 1.
    Austin PC; Steyerberg EW; Putter H
    Stat Med; 2021 Aug; 40(19):4200-4212. PubMed ID: 33969508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of pretransplant dialysis vintage on clinical outcomes in deceased donor kidney transplant.
    Lim JH; Jeon Y; Kim DG; Kim YH; Kim JK; Yang J; Kim MS; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Cho JH;
    Sci Rep; 2022 Oct; 12(1):17614. PubMed ID: 36271226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved confidence intervals for a difference of two cause-specific cumulative incidence functions estimated in the presence of competing risks and random censoring.
    Scosyrev E
    Biom J; 2020 Oct; 62(6):1394-1407. PubMed ID: 32227361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.
    Lim HJ; Zhang X; Dyck R; Osgood N
    BMC Med Res Methodol; 2010 Oct; 10():97. PubMed ID: 20964855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Analysis in the Presence of Competing Risks: The Example of Waitlisted Kidney Transplant Candidates.
    Sapir-Pichhadze R; Pintilie M; Tinckam KJ; Laupacis A; Logan AG; Beyene J; Kim SJ
    Am J Transplant; 2016 Jul; 16(7):1958-66. PubMed ID: 26751409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of pathogen-specific clinical mastitis in the first 100 days of first lactation with productive lifetime: An observational study comparing competing risks models for death and sale with the Cox model.
    Hertl JA; Schukken YH; Tauer LW; Welcome FL; Gröhn YT
    Prev Vet Med; 2023 Apr; 213():105879. PubMed ID: 36841041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis and design of randomised clinical trials involving competing risks endpoints.
    Tai BC; Wee J; Machin D
    Trials; 2011 May; 12():127. PubMed ID: 21595883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Weight Loss Before Deceased Donor Kidney Transplantation and Posttransplantation Outcomes.
    Harhay MN; Ranganna K; Boyle SM; Brown AM; Bajakian T; Levin Mizrahi LB; Xiao G; Guy S; Malat G; Segev DL; Reich D; McAdams-DeMarco M
    Am J Kidney Dis; 2019 Sep; 74(3):361-372. PubMed ID: 31126666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling competing risks in nephrology research: an example in peritoneal dialysis.
    Teixeira L; Rodrigues A; Carvalho MJ; Cabrita A; Mendonça D
    BMC Nephrol; 2013 May; 14():110. PubMed ID: 23705871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time.
    Koo TY; Lee JH; Min SI; Lee Y; Kim MS; Ha J; Kim SI; Ahn C; Kim YS; Kim J; Huh KH; Yang J
    Kidney Int; 2021 Jul; 100(1):206-214. PubMed ID: 33647326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new measure of treatment effect in clinical trials involving competing risks based on generalized pairwise comparisons.
    Cantagallo E; De Backer M; Kicinski M; Ozenne B; Collette L; Legrand C; Buyse M; Péron J
    Biom J; 2021 Feb; 63(2):272-288. PubMed ID: 32939818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes of ABO-Incompatible Living Donor Kidney Transplantation Compared to Waiting or Deceased Donor Kidney Transplantation.
    Koo TY; Lee J; Lee Y; Kim HW; Kim BS; Huh KH; Yang J
    Am J Nephrol; 2024; 55(2):235-244. PubMed ID: 38035562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram for survival analysis in the presence of competing risks.
    Zhang Z; Geskus RB; Kattan MW; Zhang H; Liu T
    Ann Transl Med; 2017 Oct; 5(20):403. PubMed ID: 29152503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in access to kidney transplantation between Hispanic and non-Hispanic whites by geographic location in the United States.
    Arce CM; Goldstein BA; Mitani AA; Lenihan CR; Winkelmayer WC
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2149-57. PubMed ID: 24115195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential impact of size mismatch in live versus deceased donor kidney transplant.
    Vinson A; Skinner T; Kiberd B; Clark D; Tennankore K
    Clin Transplant; 2021 Jun; 35(6):e14310. PubMed ID: 33818840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-analysis for aggregated survival data with competing risks: a parametric approach using cumulative incidence functions.
    Bonofiglio F; Beyersmann J; Schumacher M; Koller M; Schwarzer G
    Res Synth Methods; 2016 Sep; 7(3):282-93. PubMed ID: 26387882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Race and Ethnicity With Live Donor Kidney Transplantation in the United States From 1995 to 2014.
    Purnell TS; Luo X; Cooper LA; Massie AB; Kucirka LM; Henderson ML; Gordon EJ; Crews DC; Boulware LE; Segev DL
    JAMA; 2018 Jan; 319(1):49-61. PubMed ID: 29297077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.